Micronuclei frequency in peripheral blood lymphocytes of thyroid cancer patients after radioiodine therapy and its relationship with metastasis

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 675, Issue 1-2, 2009, Pages 35-40

  Joseph, Lebana J ^a   Bhartiya, Uma S ^a   Raut, Yogita S ^a   Kand, Purushottam ^a   Hawaldar, Rohini W ^a   Nair, Narendra ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

Metastasis; Micronuclei; Radioiodine; Thyroid cancer

Indexed keywords

DNA; IODINE 131;

ADULT; ARTICLE; CANCER PATIENT; CONTROLLED STUDY; DNA DAMAGE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; MICRONUCLEUS TEST; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; RADIATION DOSE; RADIOISOTOPE THERAPY; THYROID CANCER;

ADOLESCENT; ADULT; FEMALE; HUMANS; IODINE RADIOISOTOPES; LYMPHOCYTES; MALE; MICRONUCLEI, CHROMOSOME-DEFECTIVE; MICRONUCLEUS TESTS; MIDDLE AGED; NEOPLASM METASTASIS; THYROID NEOPLASMS; YOUNG ADULT;

EID: 64549093730     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2009.02.004     Document Type: Article

References (43)

1. Hagmar L., Brogger L., Hansteen I.-L., Heim S., Hogstedt B., Knudsen L., Lambert B., Linnainmaa K., Mitelman F., Nordenson I., Reuterwall C., Salomaa S., Skerfving S., and Sorsa M. Cancer risk in humans predicted by increased levels of chromosomal aberrations in lymphocytes: Nordic Study Group on the Health Risk of Chromosome Damage. Cancer Res. 54 (1994) 2919-2922
2. Bonassi S., Abbondandolo A., Camurri L., Dal Pra L., DeFerrari M., Degrassi F., Forni A., Lamberti L., Lando C., Padovani P., Sbrana I., Vecchio D., and Puntoni R. Are chromosome aberrations in circulating lymphocytes predictive of future cancer onset in humans? Preliminary results of an Italian cohort study. Cancer Genet. Cytogenet. 79 (1995) 133-135
3. Tucker J.D., and Preston R.J. Chromosome aberrations, micronuclei, aneuploidy, sister chromatid exchanges and cancer risk assessment. Mutat. Res. 365 (1996) 147-159
4. Hagmar L., Stromberg U., Bonassi S., Hansteen I.-L., Knudsen L.E., Lindholm C., and Norppa H. Impact of types of lymphocyte chromosomal aberrations on human cancer risk: results from Nordic and Italian Cohorts. Cancer Res. 64 (2004) 2258-2263
5. Bonassi S., Znaor A., Ceppi M., Lando C., Chang W.P., Holland N., Kirsch-Volders M., et al. An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans. Carcinogenesis 28 (2007) 625-631
6. Leal-Garza C.H., Cerda-Flores R.M., Leal-Elizondo E., and Cortes-Gutierrez E.I. Micronuclei in cervical smears and peripheral blood lymphocytes from women with and without cervical uterine cancer. Mutat. Res. 515 (2002) 57-62
7. Lones M.A., Heerema N.A., LeBeau M.M., Perkins S.L., Kadin M.E., Kjeldsberg C.R., Sposto R., Meadows A., Siegel S., Buckley J., Finlay J., Abromowitch M., Cairo M.S., and Sanger W.G. Complex secondary chromosome abnormalities in advanced stage anaplastic large cell lymphoma of children and adolescents: a report from CCG-E08. Cancer Genet. Cytogenet. 171 (2006) 89-96
8. Hsu T.C., Pathak S., Samaan N., and Hickey R.C. Chromosome instability in patients with medullary carcinoma of the thyroid. JAMA 246 (1981) 2046-2048
9. Pathak S., Hsu T.C., Samaan N., and Hickey R.C. Cytogenetic abnormalities in a patient with hypercalcemia and papillary thyroid carcinoma. Hum Genet. 60 (1982) 291-293
10. Sigurdson A.J., Hauptmann M., Alexander B.H., Doody M.M., Thomas C.B., Struewing J.P., and Jones I.M. DNA damage among thyroid cancer and multiple cancer cases, controls and long-lived individuals. Mutat. Res. 586 (2005) 173-188
11. Violot D., M'Kacher R., Adjadj E., Dossou J., de Vathaire F., and Parmentier C. Evidence of increased chromosomal abnormalities in French Polynesian thyroid cancer patients. Eur. J. Nucl. Med. Mol. Imag. 32 (2005) 174-179
12. Bauchinger M. Quantification of low-level radiation exposure by conventional chromosome aberration analysis. Mutat. Res. 339 (1995) 177-189
13. Gil O.M., Oliveira N.G., Rodrigues A.S., Laires A., Ferreira T.C., Limbert E., and Rueff J. No evidence of increased chromosomal aberrations and micronuclei in lymphocytes from nonfamilial thyroid cancer patients prior to radiotherapy. Cancer Genet. Cytogenet. 123 (2000) 55-60
14. Erselcan T., Sungu S., Ozdemir S., Turgut B., Dogan D., and Ozdemir O. Iodine-131 treatment and chromosomal damage: in vivo dose-effect relationship. Eur. J. Nucl. Med. Mol. Imag. 31 (2004) 676-684
15. 131I ablation for papillary and follicular thyroid carcinoma. Thyroid 7 (1997) 265-271
16. Wartofsky L., Sherman S.I., Gopal J., Schlumberger M., and Hay I.D. Therapeutic controversy: the use of radioactive iodine in patients with papillary and follicular thyroid cancer. J. Clin. Endocrinol. Metab. 83 (1998) 4195-4203
17. M'Kacher R., Legal J.D., Schlumberger M., Aubert B., Beron-Gaillard N., Gaussen A., and Parmentier C. Sequential biological dosimetry after a single treatment with iodine-131 for differentiated thyroid carcinoma. J. Nucl. Med. 38 (1997) 377-380
18. Baciuchka-Palmaro M., Orsiere T., Duffaud F., Sari-Minodier I., Pompili J., Bellon L., DeMeo M., Digue L., Favre R., and Botta A. Acentromeric micronuclei are increased in peripheral blood lymphocytes of untreated cancer patients. Mutat. Res. 520 (2002) 189-198
19. Fenech M. Biomarkers of genetic damage for cancer epidemiology. Toxicology 181/182 (2002) 411-416
20. El-Zein R.A., Schabath M.B., Etzel C.J., Lopez M.S., Franklin J.D., and Spitz M.R. Cytokinesis-blocked micronucleus assay as a novel biomarker for lung cancer risk. Cancer Res. 66 (2006) 6449-6456
21. Murgia E., Ballardin M., Bonassi S., Rossi A.M., and Barale R. Validation of micronuclei frequency in peripheral blood lymphocytes as early cancer risk biomarker in a nested case-control study. Mutat. Res. 639 (2008) 27-34
22. 131I. Cancer Lett. 91 (1995) 199-204
23. Gutierrez S., Carbonell E., Galofre P., Creus A., and Marcos R. Low sensitivity of the sister chromatid exchange assay to detect the genotoxic effects of radioiodine therapy. Mutagenesis 14 (1999) 221-226
24. Ramfrez M.J., Surralles J., Galofre P., Creus A., and Marcos R. Radioactive iodine induces clastogenic and age-dependent aneugenic effects in lymphocytes of thyroid cancer patients as revealed by interphase FISH. Mutagenesis 12 (1997) 449-455
25. Ramfrez M.J., Surralles J., Galofre P., Creus A., and Marcos R. FISH analysis of 1cen-1q12 breakage, chromosome 1 numerical abnormalities and centromeric content of micronuclei in buccal cells from thyroid cancer and hyperthyroidism patients treated with radioactive iodine. Mutagenesis 14 (1999) 121-127
26. Watanabe N., Yokoyama K., Kinuya S., Shuke N., Shimuzu M., Futasuya R., Michigishi T., Tonami N., Set H., and Goodwin D.A. Radiotoxicity after iodine-131 therapy for thyroid cancer using the micronucleus assay. J. Nucl. Med. 39 (1998) 436-440
27. Gil O.M., Oliveira N.G., Rodrigues A.S., Laires A., Ferrira T.C., Limbert E., Leonard A., Gerber G., and Rueff J. Cytogenetic alterations and oxidative stress in thyroid cancer patients after iodine-131 therapy. Mutagenesis 15 (2000) 69-75
28. Lee T.K., Allison R.R., O'Brien K.F., Naves J.L., Karlsson U.L., and Wiley A.L. Persistence of micronuclei in lymphocytes of cancer patients after radiotherapy. Rad. Res. 157 (2002) 678-684
29. Ballardin M., Gemignani F., Bodei L., Mariani G., Ferdeghini M., Rossi A.M., Migliore L., and Barale R. Formation of micronuclei and of clastogenic factor(s) in patients receiving therapeutic doses of iodine-131. Mutat. Res. 514 (2002) 77-85
30. Joseph L.J., Patwardhan U.N., and Samuel A.M. Frequency of micronuclei in peripheral blood lymphocytes from subjects occupationally exposed to low levels of ionizing radiation. Mutat. Res. 564 (2004) 83-88
31. Ramsey M.J., Moore II D.H., Briner J.F., Lee D.A., Olsen L.A., Senft J.R., and Tucker J.D. The effects of age and life style factors on the accumulation of cytogenetic damage as measured by chromosome painting. Mutat. Res. 338 (1995) 95-106
32. Solomon E., Borrow J., and Goddard A.D. Chromosome aberrations and cancer. Science 254 (1991) 1153-1160
33. Hagmar L., Bonassi S., Stromberg U., Brogger A., Knudsen L.E., Norppa H., Reuterwall C., and European Study Group on Cytogenetic Biomarkers and Health. Chromosomal aberrations in lymphocytes predict human cancer: A report from the European Study Group on Cytogenetic Biomarkers and Health (ESCH). Cancer Res. 58 (1998) 4117-4121
34. Berwick M., and Vineis P. Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J. Natl. Cancer Inst. 92 (2000) 874-897
35. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
36. Sanchez-Suarez P., Ostrosky-Wegman P., Gallegos-Hernandez F., Penarroja-Flores R., Toledo-Garcia J., Bravo J.L., delCastillo E.R., and Benitez-Bribiesca L. DNA damage in peripheral blood lymphocytes in patients during combined chemotherapy for breast cancer. Mutat. Res. 640 (2008) 8-15
37. Widel M., Kolosza Z., Jedrus S., Lukaszczyk B., Raczek-Zwierzycka K., and Swierniak A. Micronucleus assay in-vivo provides significant prognostic information in human cervical carcinoma; the updated analysis. Int. J. Radiat. Biol. 77 (2001) 631-636
38. Venkatachalam P., Paul S., Mohankumar M., Karthikeya Prabhu B., Gajendiran N., Kathiresan A., and Jeevanram R. Higher frequency of dicentrics and micronuclei in peripheral blood lymphocytes of cancer patients. Mutat. Res. 425 (1999) 1-8
39. Kirsch-Volders M., and Fenech M. Inclusion of micronuclei in non-divided mononuclear lymphocytes and necrosis/apoptosis may provide a more comprehensive cytokinesis block micronucleus assay for biomonitoring purposes. Mutagenesis 16 (2000) 51-58
40. Iarmarcovai G., Ceppi M., Botta A., Orsiere T., and Bonassi S. Micronuclei frequency in peripheral blood lymphocytes of cancer patients: a meta-analysis. Mutat. Res. 659 (2008) 274-283
41. 131I exposure: study in hyperthyroidism patients. Mutat. Res. 373 (1997) 39-45
42. Popova L., Hadjidekova V., Hadjieva T., Agova S., and Vasilev I. Cytokinesis-block micronucleus test in patients undergoing radioiodine therapy for differentiated thyroid carcinoma. Hell J. Nucl. Med. 8 1 (2005) 54-57
43. Ortesen J. On age of human white cells in peripheral blood. Acta Physiol. Scand. 32 (1954) 75-93